Gimm Oliver, Ukkat Jörg, Niederle Barbara E, Weber Theresa, Thanh Phuong Nguyen, Brauckhoff Michael, Niederle Bruno, Dralle Henning
Department of General, Visceral and Vascular Surgery, University of Halle, Ernst-Grube-Strasse 40, D-06097 Halle, Germany.
World J Surg. 2004 Dec;28(12):1312-6. doi: 10.1007/s00268-004-7640-9. Epub 2004 Nov 4.
In hereditary medullary thyroid carcinoma (MTC), recommendations regarding timing and extent of surgery are mainly based on the data of patients with the codon 634 RET mutation, which is the most often affected codon. Little is known about whether these recommendations may also be applied to patients with less common RET mutations. We ascertained the data from 140 patients with FMTC/MEN2A-related RET mutation not affecting codon 634 who have been treated at three specialized centers. The several RET mutations found affected codons 611 (n = 17), 618 (n = 22), 620 (n = 17), 768 (n = 9), 790 (n = 24), 791 (n = 21), 804 (n = 23), and 891 (n = 7). For each codon, the age of the youngest patient with MTC only (41, 7, 18, 29, 13, 47, 20, and 15 years, respectively), MTC with lymph node metastases (46, 24, 21, 34, 46, 47, 50, and 76 years, respectively), and MTC with distant metastases (52, 69, 43, 68, 57, - , - , and 75 years, respectively) was determined. All patients with lymph node metastases had elevated basal calcitonin levels. Based on these data, a more individual recommendation regarding timing and extent of surgery can be given. Because neither gender nor the type of nucleotide substitution for a specific codon appeared to have a significant influence on the age of onset, this recommendation should be based on the affected codon, the age of the patient, and the calcitonin level. Recurrent laryngeal nerve palsy (n = 6) and hypoparathyroidism (n = 3) were rather rare and were found only in patients older than 30 and 43 years, respectively, giving evidence that surgery in young patients can be performed safely.
在遗传性甲状腺髓样癌(MTC)中,关于手术时机和范围的建议主要基于密码子634 RET突变患者的数据,该密码子是最常受影响的密码子。对于这些建议是否也适用于具有较少见RET突变的患者,人们了解甚少。我们确定了在三个专业中心接受治疗的140例不影响密码子634的与家族性MTC/多发性内分泌腺瘤2A相关的RET突变患者的数据。发现的几种RET突变影响密码子611(n = 17)、618(n = 22)、620(n = 17)、768(n = 9)、790(n = 24)、791(n = 21)、804(n = 23)和891(n = 7)。对于每个密码子,分别确定了仅患有MTC的最年轻患者(分别为41、7、18、29、13、47、20和15岁)、伴有淋巴结转移的MTC患者(分别为46、24、21、34、46、47、50和76岁)以及伴有远处转移的MTC患者(分别为52、69、43、68、57、 - 、 - 和75岁)的年龄。所有伴有淋巴结转移的患者基础降钙素水平均升高。基于这些数据,可以给出关于手术时机和范围的更个体化建议。由于性别和特定密码子的核苷酸替代类型似乎均对发病年龄无显著影响,因此该建议应基于受影响的密码子、患者年龄和降钙素水平。喉返神经麻痹(n = 6)和甲状旁腺功能减退(n = 3)相当罕见,分别仅在年龄大于30岁和43岁的患者中发现,这表明年轻患者可以安全地进行手术。